With Bharat Biotech planning to ramp up its capacities for vaccine productions, Borosil could be a major beneficiary.
The stock has just completed a breakout retest and we could look for a bounce from here. (buy only if it bounces, else we'll look for a bounce around 206) Long after bounce around current price. SL below 205. I would double my allocation above the marked price of 245 for much higher targets.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.